SE0103722D0 - Novel formulation - Google Patents
Novel formulationInfo
- Publication number
- SE0103722D0 SE0103722D0 SE0103722A SE0103722A SE0103722D0 SE 0103722 D0 SE0103722 D0 SE 0103722D0 SE 0103722 A SE0103722 A SE 0103722A SE 0103722 A SE0103722 A SE 0103722A SE 0103722 D0 SE0103722 D0 SE 0103722D0
- Authority
- SE
- Sweden
- Prior art keywords
- pectin
- salt
- alginic acid
- composition
- gas
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title 1
- 239000001814 pectin Substances 0.000 abstract 4
- 235000010987 pectin Nutrition 0.000 abstract 4
- 229920001277 pectin Polymers 0.000 abstract 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 2
- 235000010443 alginic acid Nutrition 0.000 abstract 2
- 239000000783 alginic acid Substances 0.000 abstract 2
- 229920000615 alginic acid Polymers 0.000 abstract 2
- 229960001126 alginic acid Drugs 0.000 abstract 2
- 150000004781 alginic acids Chemical class 0.000 abstract 2
- 239000007789 gas Substances 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- AEMOLEFTQBMNLQ-BZINKQHNSA-N D-Guluronic Acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-BZINKQHNSA-N 0.000 abstract 1
- 229940069428 antacid Drugs 0.000 abstract 1
- 239000003159 antacid agent Substances 0.000 abstract 1
- 230000001458 anti-acid effect Effects 0.000 abstract 1
- 239000011260 aqueous acid Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 150000004702 methyl esters Chemical class 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000000737 potassium alginate Substances 0.000 abstract 1
- 235000010408 potassium alginate Nutrition 0.000 abstract 1
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 abstract 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 abstract 1
- 235000015497 potassium bicarbonate Nutrition 0.000 abstract 1
- 239000011736 potassium bicarbonate Substances 0.000 abstract 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000000661 sodium alginate Substances 0.000 abstract 1
- 235000010413 sodium alginate Nutrition 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 1
- 239000002341 toxic gas Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103722A SE0103722D0 (sv) | 2001-10-30 | 2001-10-30 | Novel formulation |
| US10/493,720 US20050063980A1 (en) | 2001-10-30 | 2002-10-29 | Gastric raft composition |
| PCT/SE2002/001957 WO2003037300A1 (en) | 2001-10-30 | 2002-10-29 | Gastric raft composition |
| JP2003539644A JP2005507409A (ja) | 2001-10-30 | 2002-10-29 | 胃内ラフト組成物 |
| EP02782055A EP1441694A1 (en) | 2001-10-30 | 2002-10-29 | Gastric raft composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103722A SE0103722D0 (sv) | 2001-10-30 | 2001-10-30 | Novel formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0103722D0 true SE0103722D0 (sv) | 2001-10-30 |
Family
ID=20285916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0103722A SE0103722D0 (sv) | 2001-10-30 | 2001-10-30 | Novel formulation |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20050063980A1 (enExample) |
| EP (1) | EP1441694A1 (enExample) |
| JP (1) | JP2005507409A (enExample) |
| SE (1) | SE0103722D0 (enExample) |
| WO (1) | WO2003037300A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2343890T3 (es) | 2003-09-08 | 2010-08-12 | Fmc Biopolymer As | Espuma gelificada a base de biopolimero. |
| AU2006340298B2 (en) * | 2006-03-16 | 2012-10-04 | Glycologic Limited | Gastric raft composition comprising preferably processed starches for inducing satiety |
| MY171835A (en) | 2012-12-25 | 2019-11-01 | Taisho Pharmaceutical Co Ltd | Aqueous carbonated beverage |
| WO2020011938A1 (en) | 2018-07-11 | 2020-01-16 | Medizinische Universität Wien | Glucocorticoids for the topical treatment of autoimmune gastritis |
| US20240423938A1 (en) * | 2023-06-26 | 2024-12-26 | Reflux Gourmet Llc | Functional gum comprising an alginate blend |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1524740A (en) * | 1976-11-09 | 1978-09-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions for use in the suppression of gastric reflux |
| US5888540A (en) * | 1993-10-29 | 1999-03-30 | Sugden; Keith | Pharmaceutical products |
| WO1995011668A1 (en) * | 1993-10-29 | 1995-05-04 | Reckitt & Colman Products Limited | Gelatin capsule fill able to foam |
-
2001
- 2001-10-30 SE SE0103722A patent/SE0103722D0/xx unknown
-
2002
- 2002-10-29 US US10/493,720 patent/US20050063980A1/en not_active Abandoned
- 2002-10-29 EP EP02782055A patent/EP1441694A1/en not_active Withdrawn
- 2002-10-29 JP JP2003539644A patent/JP2005507409A/ja active Pending
- 2002-10-29 WO PCT/SE2002/001957 patent/WO2003037300A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1441694A1 (en) | 2004-08-04 |
| WO2003037300A1 (en) | 2003-05-08 |
| JP2005507409A (ja) | 2005-03-17 |
| US20050063980A1 (en) | 2005-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2003002742A0 (en) | Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids | |
| GEP20074078B (en) | Fluoro substituted cyclo-alkanoindoles, compositions comprising them and their use | |
| AU2003275958A1 (en) | Muteins of tear lipocalin | |
| BR0214279A (pt) | Composições farmacêuticas em forma particulada | |
| BR0316532A (pt) | Composições farmacêuticas compreendendo, um composto de droga básico, respectivamente um ácido, um tensoativo e um ácido solúvel em água fisiologicamente tolerável, respectivamente, uma base | |
| IS7574A (is) | Fenýlalkanósýra og fenýloxýalkanósýru afleiður sem HPPAR virkjar | |
| CA2448035A1 (en) | New pharmaceutical composition | |
| NO20075920L (no) | Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria | |
| NO20032371L (no) | Makrolidsolvater | |
| MXPA05008403A (es) | Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion. | |
| JP2001527022A5 (enExample) | ||
| UY27229A1 (es) | Composición | |
| DE60205629D1 (en) | Akarizidpulver | |
| UA89349C2 (uk) | Таблетка без покриття, яка містить оланзапін, та спосіб її одержання | |
| WO2006132568A3 (en) | Fire-extinguishing composition | |
| DE60313192D1 (de) | Rauch erzeugende zusammensetzung | |
| MXPA03010055A (es) | Analogos de 17-metileno-androstan-3a-ol como inhibidores de hlc. | |
| RU2011108370A (ru) | Жевательная композиция, включающая альгинат, бикарбонат и карбонат | |
| RU2007103195A (ru) | Пероральная композиция тедисамила с замедленным высвобождением, обладающая свойством задержки в желудке | |
| HU0401170D0 (en) | New pharmaceutical composition and process for producing it | |
| DE60219462D1 (de) | Verdickte wässrige zusammensetzungen | |
| EA200900249A1 (ru) | Фармацевтическая композиция и способ ее получения | |
| AU2003294405A1 (en) | Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol | |
| JP2005507409A5 (enExample) | ||
| US20050063980A1 (en) | Gastric raft composition |